维普中文期刊产品整合服务

PI3K/Akt/mTOR signaling orchestrates the phenotypic transition and chemo-resistance of small cell lung cancer

查看全文 作　　者：Xuefeng [1,2,3]Li;Cheng [3]Li;Chenchen [1,2]Guo;Qiqi [1,2,4]Zhao;Jiayu [2,5]Cao;Hsin-Yi [1]Huang;Meiting [1,2]Yue;Yun [1,2]Xue;Yujuan [1]Jin;Liang [1]Hu;Hongbin [1,2,4,6]Ji 高影响力作者 机构地区：[1]State Key Laboratory of Cell Biology,Shanghai Institute of Biochemistry and Cell Biology,Center for Excellence in Molecular Cell Science,Chinese Academy of Sciences,Shanghai 200031,China;[2]University of Chinese Academy of Sciences,Beijing 100049,China;[3]Department of Medical Oncology,The First Affiliated Hospita,Hengyang MedicalSchool,University of South China,Hengyang,Hunan 421001,China;[4]School of Life Science and Technology,Shanghai Tech University,Shanghai 200120,China;[5]CAS Key Laboratory of Computational Biology,CAS-MPG Partner Institute for Computational Biology,Shanghai Institute of Nutrition and Health,Shanghai Institutes for Biological Sciences,Chinese Academy of Sciences,Shanghai 200031,China;[6]School of Life Science,Hangzhou Institute for Advanced Study,University of Chinese Academy of Sciences,Hangzhou 310024,China高影响力机构 出　　处：《Journal of Genetics and Genomics》索引2021年第48卷第7期,共12页高影响力期刊 基　　金：supported by the National Natural Science Foundation of China(82030083 to H.J.,81871875 to L.H.);the National Basic Research Program of China(2017YFA0505501 to H.J.;2020YFA0803300 to H.J.);the Strategic Priority Research Program of the Chinese Academy of Sciences(XDB19020201 to H.J.);the National Natural Science Foundation of China(81872312 to H.J.,82011540007 to H.J.,31621003 to H.J.,81402371 to Y.J.,81802279 to H.H.,81902326 to X.W.,81602443 to X.L.);the Basic Frontier Scientific Research Program of Chinese Academy of Science(ZDBSLY-SM006 to H.J.);the International Cooperation Project of Chinese Academy of Sciences(153D31KYSB20190035 to H.J.);the Youth Innovation Promotion Association CAS(Y919S31371 to X.W.);the Natural Science Foundation of Hunan Province,China(2019JJ50550 to X.L.);Clinical Medical Technology Innovation Guide Project of Hunan(2020SK51827 to X.L.);Project of Scientific Research Plan of Hunan Provincial Health Commission(202103100127 to X.L.)。 摘　　要：Small cell lung cancer(SCLC)is a phenotypically heterogeneous disease with an extremely poor prognosis,which is mainly attributed to the rapid development of resistance to chemotherapy.However,the relation between the growth phenotypes and chemo-resistance of SCLC remains largely unclear.Through comprehensive bioinformatic analyses,we found that the heterogeneity of SCLC phenotype was significantly associated with different sensitivity to chemotherapy.Adherent or semiadherent SCLC cells were enriched with activation of the PI3K/Akt/mTOR pathway and were highly chemoresistant.Mechanistically,activation of the PI3K/Akt/mTOR pathway promotes the phenotypic transition from suspension to adhesion growth pattern and confers SCLC cells with chemo-resistance.Such chemo-resistance could be largely overcome by combining chemotherapy with PI3K/Akt/mTOR pathway inhibitors.Our findings support that the PI3K/Akt/mTOR pathway plays an important role in SCLC phenotype transition and chemo-resistance,which holds important clinical implications for improving SCLC treatment. 关 键 词：SCLC Heterogeneity Growth pattern Phenotype transition Drug resistance PI3K/Akt/mTOR pathway
相关文献

参考文献(50)

引证文献(7)

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费